A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients

I.E.L.M. Kuppens; E.O. Witteveen; R.C. Jewell; S.A Radema; E.M. Paul; S.G. Mangum; J.H. Beijnen; E.E. Voest; J.H.M. Schellens

A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients

I.E.L.M. Kuppens, E.O. Witteveen, R.C. Jewell, S.A Radema, E.M. Paul, S.G. Mangum, J.H. Beijnen, E.E. Voest, J.H.M. Schellens

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	3276-3285
Number of pages	10
Journal	Clinical Cancer Research
Volume	13
Issue number	11
Publication status	Published - 2007

Cite this

@article{46678d215d0e4f8ca4079615b6e75f6e,

title = "A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients",

author = "I.E.L.M. Kuppens and E.O. Witteveen and R.C. Jewell and S.A Radema and E.M. Paul and S.G. Mangum and J.H. Beijnen and E.E. Voest and J.H.M. Schellens",

note = "1078-0432",

year = "2007",

language = "Undefined/Unknown",

volume = "13",

pages = "3276--3285",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "11",

}

TY - JOUR

T1 - A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients

AU - Kuppens, I.E.L.M.

AU - Witteveen, E.O.

AU - Jewell, R.C.

AU - Radema, S.A

AU - Paul, E.M.

AU - Mangum, S.G.

AU - Beijnen, J.H.

AU - Voest, E.E.

AU - Schellens, J.H.M.

N1 - 1078-0432

PY - 2007

Y1 - 2007

M3 - Article

SN - 1078-0432

VL - 13

SP - 3276

EP - 3285

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 11

ER -